Timcodar

Star0

DB12761InvestigationalSmall molecule

Timcodar has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

Formula / weight: C₄₃H₄₅ClN₄O₆ · 749.31 g/mol (avg)
Code names: VX-853

Resolves to

Compound

UNIIU141W322WZCAS179033-51-3ChEMBLCHEMBL2059028PubChem9811664

Structure

InChIKeyMQSMWZHHUGSULF-QNGWXLTQSA-NSMILESCOC1=CC(=CC(OC)=C1OC)C(=O)C(=O)N(C)[C@@H](CC1=CC=C(Cl)C=C1)C(=O)N(CC1=CC=CC=C1)C(CCC1=CC=NC=C1)CCC1=CC=NC=C1

Targets

P37231PPARG

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Timcodar, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account